US FDA approves new oral drug for rare genetic disorder phenylketonuria

US FDA approves new oral drug for rare genetic disorder phenylketonuria
The FDA approved PTC Therapeutics' new oral drug Sephience for treating phenylketonuria, a rare genetic disorder. It offers a new option as existing treatments face lim
Read more...